Peptide record

TPDB42892

2A(F39-Q58) Anticancer standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42892
2A(F39-Q58)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 30-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ
Physicochemical Analysis
C168H260N62O41
CEHKMPV
R
3804.30
12.50
9
1
10
+8
2.11
-1.410
42.33
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
8480
222.91
8
Residue Composition
number
1
A
9
R
2
N
1
D
0
C
0
E
2
Q
4
G
0
H
1
I
2
L
0
K
0
M
3
F
0
P
1
S
1
T
1
W
2
Y
0
V
Amino Acid Distribution
A: 1 R: 9 N: 2 D: 1 C: 0 E: 0 Q: 2 G: 4 H: 0 I: 1 L: 2 K: 0 M: 0 F: 3 P: 0 S: 1 T: 1 W: 1 Y: 2 V: 0
Chemical Descriptors
30
C168H260N62O41
3804.30
12.50
+8
2.11
-1.410
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-C
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.